For example, although early clinical trials of Listeria - based vaccines have shown that the neutralized bacterium produces only mild flulike symptoms in
human patients
with cervical cancer, the various methods of genetically disarming the bacteria should be explored to find the safest approach for people gravely ill
with pancreatic cancer, because these patients are likely to already have
weak immune systems.